Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 275
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

REVIEW ARTICLE

The role of pharmacoeconomics in current Indian healthcare system

Ahmad Akram, Patel Isha, Parimilakrishnan Sundararajan, Mohanta Guru Prasad, Chung HaeChung, Chang Jongwha

Year : 2013| Volume: 2| Issue : 1 | Page no: 3-9

   This article has been cited by
 
1 Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy
Raushan Kumar Chaudhary,Melwin Johns Philip,Ashly Santhosh,Satish S. Karoli,Ramesh Bhandari,M.S. Ganachari
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(6): 102303
[Pubmed]  [Google Scholar] [DOI]
2 Assessing the Application of Pharmacoeconomic Evaluations in Medicines Management by Hospital Pharmacists in Nigeria: A Cross-Sectional Survey
Theophilus Ehidiamen Oamen, Kanayo Patrick Osemene, Romanus Maduabuchi Ihekoronye
Hospital Topics. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair!
Renu Suthar, Amol N Patil
Annals of Neurosciences. 2021; : 0972753121
[Pubmed]  [Google Scholar] [DOI]
4 Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patientsImpact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients
BhavyaH Vyas,NishitaH Darji,DevangA Rana,KaushalY Vyas,SupriyaD Malhotra
Perspectives in Clinical Research. 2021; 12(2): 76
[Pubmed]  [Google Scholar] [DOI]
5 A retrospective cross-sectional descriptive study to critically appraise the quality of reporting of health economic evaluations conducted in the Indian setting
SandeepKumar Gupta,RaviKant Tiwari,RajKumar Goel
Perspectives in Clinical Research. 2021; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
6 Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
Kamal Sharma, A B Chandorkar, Rajiv Kovil , S Venkataraman , KAV Subrahmanyam , Parthasarathi Mandal , Jasjeet Wasir , Mahesh Abhyankar, Ashish Prasad , Prashant S Sarda
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 COST ANALYSIS OF DISEASE MODIFYING ANTI RHEUMATIC DRUGS: THE INDIAN SCENARIO
Zarrin Ansari,Sharmada Nerlekar,Sagar Karia,Sudhir Pawar
GLOBAL JOURNAL FOR RESEARCH ANALYSIS. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
8 Assessment of the quality and trend of reporting of health economic evaluation research in India
Sonali Karekar,Yashashri Shetty
Expert Review of Pharmacoeconomics & Outcomes Research. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 Urgency of the Implementation of Health Technology Assessment to Support Indonesian National Health Security System
Gunawan Widjaja,Hotmaria H. Sijabat
IOP Conference Series: Materials Science and Engineering. 2019; 508: 012144
[Pubmed]  [Google Scholar] [DOI]
10 Knowledge Assessment of E-Bug Assisted Antimicrobial Resistance Education Module in Class VII School Students of South Indian Coastal Town of Manipal
Reona Fernandes,Swathi Naik,Archana-Gururaj Bhat,Rashmi Shetty,Manjunatha-H Hande,Abdul Ghafur,Mahadev Rao,Vijayanarayana Kunhikatta,John-Preshanth-Kumar Pathiraj
Journal of Clinical Medicine. 2019; 8(1): 84
[Pubmed]  [Google Scholar] [DOI]
11 Evaluation and Characterization of Health Economics and Outcomes Research in SAARC Nations
Manthan Mehta,Rajan Nerurkar
Therapeutic Innovation & Regulatory Science. 2018; 52(3): 348
[Pubmed]  [Google Scholar] [DOI]

 

Read this article